PAREXEL Early Phase Clinical Unit — Glendale, California

PAREXEL Early Phase Clinical Unit is a clinical research site located in Glendale, California, United States 91206.

Crixeo Clinical Trials Trust Score: 12/100 (FAILING). This profile has not yet been claimed by the site owner.

PAREXEL Early Phase Clinical Unit has participated in 5 clinical trials with 1 currently active.

Therapeutic areas: Healthy Volunteers (HV), Major Depressive Disorder, Drug Drug Interaction.

Sponsors: Jade Biosciences, Inc., Taisho Pharmaceutical R&D Inc., VistaGen Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Glendale

Browse all research sites in California · View every site in Glendale

Sponsor Feasibility Report

Trust Score: 12/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for PAREXEL Early Phase Clinical Unit?

PAREXEL Early Phase Clinical Unit has a Crixeo Trust Score of 12/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has PAREXEL Early Phase Clinical Unit conducted?

PAREXEL Early Phase Clinical Unit has 5 clinical trials on record, with 1 currently active. Their work covers Healthy Volunteers (HV), Major Depressive Disorder, Drug Drug Interaction.

Is PAREXEL Early Phase Clinical Unit accredited by Crixeo Clinical Trials?

PAREXEL Early Phase Clinical Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about PAREXEL Early Phase Clinical Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.